EW
$82.50+0.04 (+0.05%)
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Recent News
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now?
Is EW a good stock to buy? We came across a bullish thesis on Edwards Lifesciences Corporation Torre Financial Newsletter’s Substack by Federico Torre. In this article, we will summarize the bulls’ thesis on EW. Edwards Lifesciences Corporation’s share was trading at $83.92 as of March 16th. EW’s trailing and forward P/E were 46.17 and 28.49 respectively according to Yahoo Finance. Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in th
Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?
Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH expands via acquisitions and global growth, but biotech funding softness, U.S. academic spending pressure and competition cloud near-term outlook.
Edwards Lifesciences (EW) Valuation Check After Recent Share Price Momentum
What Edwards Lifesciences stock’s recent move might be telling you Edwards Lifesciences (EW) has attracted attention after a 2.1% daily gain, set against mixed recent returns including a roughly 10.1% rise over the past month and a small decline over the past 3 months. See our latest analysis for Edwards Lifesciences. At a share price of $83.56, Edwards Lifesciences pairs a 10.1% 1 month share price return with a 2.1% year to date decline, while its 1 year total shareholder return sits at...
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART faces macro headwinds and tight liquidity, but strong demand in its Codman Specialty Surgical unit and expanding international launches could support growth.